216 filings
8-K
CLB
Core Laboratories Inc
26 Apr 23
Results of Operations and Financial Condition
4:55pm
8-K
CLB
Core Laboratories Inc
3 Apr 23
Submission of Matters to a Vote of Security Holders
6:17pm
8-K
CLB
Core Laboratories Inc
3 Feb 23
Q4 2022 Earnings Conference Call
2:55pm
8-K
CLB
Core Laboratories Inc
1 Feb 23
Fourth Quarter Revenue of $128 Million; Up Slightly Sequentially
5:00pm
8-K
CLB
Core Laboratories Inc
17 Jan 23
Core Lab Announces Proposed Redomestication to the United States
4:23pm
8-K
ffvip oci
4 Nov 22
Core Lab Announces Voluntary Delisting from Euronext Amsterdam
5:01pm
8-K
atr mdf855c7
26 Oct 22
Third Quarter Revenue of $126 Million; Up 4% Sequentially; Up 7% Year-over-year
5:00pm
8-K
eby 2md6jpw9
27 Jul 22
Second Quarter Revenue of $120.9 Million; Up 5% Sequentially; Up 2% Year-over-year
5:00pm
8-K
t9n7ogskrdp536poaja
26 Jul 22
Entry into a Material Definitive Agreement
6:21pm
8-K
rq64xlb0vch
9 Jun 22
Core Lab Announces $60,000,000 “At-the-market” Equity Offering Program
8:40am
8-K
qx4jucik3oqj
8 Jun 22
Other Events
4:43pm
8-K
pov4khkqn11
19 May 22
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
9c9ltrmn jbh6c6kh3p
27 Apr 22
First Quarter Revenue of $115.3 Million; Up 6% Year-over-year
5:01pm
8-K
mxz6vy6ptzdf 0l1ezx
16 Mar 22
Regulation FD Disclosure
5:05pm
8-K
z0krkm gwo7xo6el
2 Feb 22
Fourth Quarter Revenue of $125.1 Million; Up 6% Sequentially; Up 10% Year-over-year
5:16pm
8-K
j9dp4p1k
27 Oct 21
Results of Operations and Financial Condition
4:51pm
8-K
zx6f2pslt j1d
19 Oct 21
Departure of Directors or Certain Officers
4:52pm
8-K
0cc8y
28 Jul 21
Results of Operations and Financial Condition
5:04pm
8-K
vjthhqyg 81a2k
19 May 21
Submission of Matters to a Vote of Security Holders
5:30pm
8-K
7w9r4dt6ql5sb5 j30p
21 Apr 21
Company First Quarter Revenue of $108.4 Million; Down 4.7% Sequentially
5:05pm